Physician profile
John W Secor
NPI 1568421014
$1,580.16
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $921 · 2020: $550 · 2021: $12.96 · 2022: $13.73 · 2024: $82.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $82.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $82.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $928.68 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $114.51 | 2019-2020 | |
| Gilead Sciences, INC. | $96.07 | 2022-2024 | |
| Janssen Biotech, INC. | $86.38 | 2019 | |
| Qol Medical, LLC | $84.63 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.52 | 2020-2021 | |
| Shionogi INC | $36.19 | 2019 | |
| Endo Pharmaceuticals INC. | $30.51 | 2019 | |
| Ucb, INC. | $26.42 | 2019-2020 | |
| Ethicon US, LLC | $19.14 | 2019 | |
| Daiichi Sankyo INC. | $17.92 | 2020 | |
| Ironwood Pharmaceuticals, INC | $16.92 | 2019 | |
| Redhill Biopharma INC. | $15.56 | 2020 | |
| Ferring Pharmaceuticals INC. | $14.96 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $14.69 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.50 | 2020 | |
| Allergan, INC. | $12.56 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Secor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.